{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:51:07Z","timestamp":1770220267184,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T00:00:00Z","timestamp":1529712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11940-018-0515-4","type":"journal-article","created":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T04:20:52Z","timestamp":1529727652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Anti-IgLON 5 Disease"],"prefix":"10.1007","volume":"20","author":[{"given":"Anna","family":"Heidbreder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstanze","family":"Philipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,23]]},"reference":[{"key":"515_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"\u2022\u2022 Sabater L, Gaig C, Gelpi E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and postmortem study. Lancet Neurol. 2014;13:575\u201386. This original research article describes the entity of IgLON-5 for the first time and its association to a new sleep disorder in eight patients.","journal-title":"Lancet Neurol"},{"key":"515_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","volume":"132","author":"E Gelpi","year":"2016","unstructured":"Gelpi E, H\u00f6ftberger R, Graus F, Ling H, Holton JL, Dawson T, et al. Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol. 2016;132:531\u201343.","journal-title":"Acta Neuropathol"},{"key":"515_CR3","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"\u2022\u2022 Gaig C, Graus F, Compta Y, et al. Clinical manifestations of the anti-IgLON5 disease. Neurology. 2017;88:1736\u201343. This original research article describes the today known different types of the anti-IgLON5 disease in 22 patients.","journal-title":"Neurology"},{"key":"515_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","volume":"13","author":"L Sabater","year":"2016","unstructured":"Sabater L, Planaguma J, Dalmau J, Graus F. Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome. J Neuroinflammation. 2016;13:226.","journal-title":"J Neuroinflammation"},{"key":"515_CR5","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1212\/WNL.0000000000004541","volume":"89","author":"D Escudero","year":"2017","unstructured":"Escudero D, Guasp M, Ari\u00f1o H, Gaig C, Mart\u00ednez-Hern\u00e1ndez E, Dalmau J, et al. Antibody-associated CNS syndromes without signs of inflammation in the elderly. Neurology. 2017;89:1471\u20135.","journal-title":"Neurology"},{"key":"515_CR6","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1212\/NXI.0000000000000383","volume":"4","author":"M Bonello","year":"2017","unstructured":"Bonello M, Jacob A, Ellul MA, Barker E, Parker R, Jefferson S, et al. IgLON5 disease responsive to immunotherapy. Neurol Neuroimmunol Neuroinflamm. 2017;4:e383.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"515_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/mds.26608","volume":"31","author":"N Bruggemann","year":"2016","unstructured":"Bruggemann N, Wandinger KP, Gaig C, et al. Dystonia, lower limb stiffness, and upward gaze palsy in a patient with IgLON5 antibodies. Mov Disord. 2016;31:762\u20134.","journal-title":"Mov Disord"},{"key":"515_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneuroim.2016.09.012","volume":"300","author":"R Haitao","year":"2016","unstructured":"Haitao R, Yingmai Y, Yan H, Fei H, Xia L, Honglin H, et al. Chorea and parkinsonism associated with autoantibodies to IgLON5 and responsive to immunotherapy. J Neuroimmunol. 2016;300:9\u201310.","journal-title":"J Neuroimmunol"},{"key":"515_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jneuroim.2017.05.019","volume":"310","author":"R Haitao","year":"2017","unstructured":"Haitao R, Huiqin L, Tao Q, Xunzhe Y, Xiaoqiu S, Wei L, et al. Autoimmune encephalitis associated with vitiligo? J Neuroimmunol. 2017;310:14\u20136.","journal-title":"J Neuroimmunol"},{"key":"515_CR10","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(15)60445-7","volume":"385","author":"B H\u00f6gl","year":"2015","unstructured":"H\u00f6gl B, Heidbreder A, Santamaria J, Graus F, Poewe W. IgLON5 autoimmunity and abnormal behaviours during sleep. Lancet. 2015;385:1590.","journal-title":"Lancet"},{"key":"515_CR11","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1212\/NXI.0000000000000136","volume":"2","author":"MM Simabukuro","year":"2015","unstructured":"Simabukuro MM, Sabater L, Adoni T, Cury RG, Haddad MS, Moreira CH, et al. Sleep disorder, chorea, and dementia associated with IgLON5 antibodies. Neurol Neuroimmunol Neuroinflamm. 2015;2:e136.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"515_CR12","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1212\/NXI.0000000000000302","volume":"4","author":"JB Schroder","year":"2017","unstructured":"Schroder JB, Melzer N, Ruck T, et al. Isolated dysphagiaas initial sign of anti-IgLON5 syndrome. Neurol Neuroimmunol Neuroinflamm. 2017;4:e302.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"515_CR13","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000385","volume":"4","author":"JA Honorat","year":"2017","unstructured":"Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, et al. IgLON5antibody: neurological accompaniments and outcomes in20 patients. Neurol Neuroimmunol Neuroinflamm. 2017;4:e385.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"515_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/RLU.0000000000001339","volume":"41","author":"W Zhang","year":"2016","unstructured":"Zhang W, Niu N, Cui R. Serial 18F-FDG PET\/CT findings in a patient with IgLON5 encephalopathy. Clin Nucl Med. 2016;41:787\u20138.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"515_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jsmc.2017.09.005","volume":"13","author":"A Iranzo","year":"2018","unstructured":"Iranzo A. Parasomnias and sleep-related movement disorders in older adults. Sleep Med Clin. 2018;13(1):51\u201361.","journal-title":"Sleep Med Clin"},{"key":"515_CR16","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1212\/NXI.0000000000000393","volume":"4","author":"F Graus","year":"2017","unstructured":"Graus F, Santamar\u00eda J. Understanding anti-IgLON5 disease. Neurol Neuroimmunol Neuroinflamm. 2017;4:e393.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"515_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3233\/JND-170259","volume":"4","author":"S Wenninger","year":"2017","unstructured":"Wenninger S. Expanding the clinical spectrum of IgLON5-syndrome. J Neuromuscul Dis. 2017;4(4):337\u20139.","journal-title":"J Neuromuscul Dis"},{"key":"515_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.parkreldis.2017.03.002","volume":"38","author":"S Mangesius","year":"2017","unstructured":"Mangesius S, Sprenger F, H\u00f6ftberger R, Seppi K, Reindl M, Poewe W. IgLON5 autoimmunity tested negative in patients with progressive supranuclear palsy and corticobasal syndrome. Parkinsonism Relat Disord. 2017;38:102\u20133. \n                      https:\/\/doi.org\/10.1016\/j.parkreldis.2017.","journal-title":"Parkinsonism Relat Disord"},{"key":"515_CR19","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1111\/ene.13566","volume":"25","author":"K Hasselbacher","year":"2018","unstructured":"Hasselbacher K, Steffen A, Wandinger KP, Br\u00fcggemann N. IgLON5 antibodies are infrequent in patients with isolated sleep apnea. Eur J Neurol. 2018 Apr;25:e46\u20137.","journal-title":"Eur J Neurol"},{"key":"515_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.schres.2017.04.027","volume":"192","author":"O Mantere","year":"2018","unstructured":"Mantere O, Saarela M, Kiesepp\u00e4 T, Raij T, M\u00e4ntyl\u00e4 T, Lindgren M, et al. Anti-neuronal anti-bodies in patients with early psychosis. Schizophr Res. 2018;192:404\u20137.","journal-title":"Schizophr Res"},{"key":"515_CR21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012;71:362\u201381.","journal-title":"J Neuropathol Exp Neurol"},{"key":"515_CR22","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","volume":"23","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol. 2010;23:394\u2013400.","journal-title":"Curr Opin Neurol"},{"key":"515_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, et al. Primaryage-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128:755\u201366.","journal-title":"Acta Neuropathol"},{"key":"515_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/9781444341256.ch15","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Wiley-Blackwell","author":"DW Dickson","year":"2011","unstructured":"Dickson DW, Hauw JJ, Agid Y, Litvan I. Progressive supranuclear palsy and corticobasal degeneration. In: Dickson DW, Weller RO, editors. Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Wiley-Blackwell. New York: Publishers; 2011. p. 135\u201355."},{"key":"515_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12208","volume":"41","author":"GG Kovacs","year":"2015","unstructured":"Kovacs GG. Neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol. 2015;41:3\u201323.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"515_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-170189","volume":"59","author":"A Cagnin","year":"2017","unstructured":"Cagnin A, Mariotto S, Fiorini M, Gaule M, Bonetto N, Tagliapietra M, et al. Microglial and neuronal TDP-43 pathology in anti-IgLON5-related tauopathy. J Alzheimers Dis. 2017;59:13\u201320.","journal-title":"J Alzheimers Dis"},{"key":"515_CR27","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"\u2022 Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev. 2017;97:839\u201387. This review article gives an excellent overview of the recently discovered and investigated pathophysiological pathways in antibody-mediated neurological disorders.","journal-title":"Physiol Rev"},{"key":"515_CR28","doi-asserted-by":"publisher","first-page":"s1304","DOI":"10.2741\/1214","volume":"8","author":"D Karagogeos","year":"2003","unstructured":"Karagogeos D. Neural GPI-anchored cell adhesion molecules. Front Biosci. 2003;8:s1304\u201320.","journal-title":"Front Biosci"},{"key":"515_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2008.05.069","volume":"1224","author":"T Hashimoto","year":"2008","unstructured":"Hashimoto T, Yamada M, Maekawa S, Nakashima T, Miyata S. IgLON cell adhesion molecule Kilon is a crucial modulator for synapse number in hippocampal neurons. Brain Res. 2008;1224:1\u201311.","journal-title":"Brain Res"},{"issue":"7","key":"515_CR30","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.1074\/jbc.M114.628438","volume":"290","author":"R Sanz","year":"2015","unstructured":"Sanz R, Ferraro GB, Fournier AE. IgLON cell adhesion molecules are shed from the cell surface of cortical neurons to promote neuronal growth. J Biol Chem. 2015;290(7):4330\u201342.","journal-title":"J Biol Chem"},{"key":"515_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ajmg.a.35841","volume":"161","author":"HM Minhas","year":"2013","unstructured":"Minhas HM, Pescosolido MF, Schwede M, Piasecka J, Gaitanis J, Tantravahi U, et al. An unbalanced translocation involving loss of 10q26.2 and gain of 11q25 in a pedigree with autism spectrum disorder and cerebellar juvenile pilocytic astrocytoma. Am J Med Genet A. 2013;161:787\u201391.","journal-title":"Am J Med Genet A"},{"key":"515_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ng1183","volume":"34","author":"GC Sellar","year":"2003","unstructured":"Sellar GC, Watt KP, Rabiasz GJ, Stronach EA, Li L, Miller EP, et al. OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer. Nat Genet. 2003;34:337\u201343.","journal-title":"Nat Genet"},{"key":"515_CR33","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/ene.12758","volume":"22","author":"MG Huijbers","year":"2015","unstructured":"Huijbers MG, Querol LA, Niks EH, Plomp JJ, van der Maarel SM, Graus F, et al. The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol. 2015;22:1151\u201361.","journal-title":"Eur J Neurol"},{"key":"515_CR34","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1468-1331.2007.01870.x","volume":"14","author":"K Ohta","year":"2007","unstructured":"Ohta K, Shigemoto K, Fujinami A, Maruyama N, Konishi T, Ohta M. Clinical and experimental features of MuSK antibody positive MG in Japan. Eur J Neurol. 2007;14:1029\u201334.","journal-title":"Eur J Neurol"},{"key":"515_CR35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ana.24195","volume":"76","author":"EH Moscato","year":"2014","unstructured":"Moscato EH, Peng X, Jain A, Parsons TD, Dalmau J, Balice-Gordon RJ. Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2014;76:108\u201319.","journal-title":"Ann Neurol"},{"key":"515_CR36","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/cbf.1600","volume":"27","author":"T Hashimoto","year":"2009","unstructured":"Hashimoto T, Maekawa S, Miyata S. IgLON cell adhesion molecules regulate synaptogenesis in hippocampal neurons. Cell Biochem Funct. 2009;27:496\u20138.","journal-title":"Cell Biochem Funct"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-018-0515-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-018-0515-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-018-0515-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T19:16:33Z","timestamp":1561230993000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-018-0515-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,23]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1007\/s11940-018-0515-4","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,23]]},"assertion":[{"value":"23 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Anna Heidbreder reports honoraria received from Servier, UCB, Bioprojet, Medice, and Fortbildungs Kolleg.Konstanze Philipp declares no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"29"}}